CUBIST PHARMACEUTICALS INC Future Amortization Expense, Year Five (Deprecated 2012-01-31)
CUBIST PHARMACEUTICALS INC reported Future Amortization Expense, Year Five (Deprecated 2012-01-31) of $19.59 million for the 6-month period ending 2012-06-30, per its 10-Q filed 2012-08-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:FutureAmortizationExpenseYearFive · last filed 2012-08-07
- CUBIST PHARMACEUTICALS INC future amortization expense, year five (deprecated 2012-01-31) for the quarter ending 2012-06-30 was $0.00.
- CUBIST PHARMACEUTICALS INC future amortization expense, year five (deprecated 2012-01-31) for the quarter ending 2012-03-31 was $19.59M.
- CUBIST PHARMACEUTICALS INC future amortization expense, year five (deprecated 2012-01-31) for fiscal 2011 was $19.59M.
| Period end | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 3 month | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 6 month | Future Amortization Expense, Year Five (Deprecated 2012-01-31) 12 month |
|---|---|---|---|
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-07 | $19.59M 10-Q · filed 2012-08-07 | |
| 2012-03-31 | $19.59M 10-Q · filed 2012-05-01 | ||
| 2011-12-31 | $19.59M 10-K · filed 2012-02-27 | ||
| 2011-06-30 | $2.52M 10-Q · filed 2011-07-29 |